Literature DB >> 7544977

Could HLA-DRB1 be the protective locus in rheumatoid arthritis?

E Zanelli1, M A Gonzalez-Gay, C S David.   

Abstract

Extensive studies in different ethnic groups have associated the susceptibility to development of rheumatoid arthritis (RA) with the third hypervariable region of the major histocompatibility complex (MHC) HLA-DR beta 1 molecule. On the basis of recent findings in the experimental mouse model of collagen-induced arthritis, Eric Zanelli, Miguel Gonzalez-Gay and Chella David propose that the HLA-DRB1 locus is associated with protection to RA and that the actual arthritogenic peptide-presenting molecule is HLA-DQ. Thus, the development of RA would depend upon the expression of the susceptible DQ allele and the nonprotective DRB1 alleles, along with environmental factors that trigger the autoimmune process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544977     DOI: 10.1016/0167-5699(95)80181-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  29 in total

Review 1.  Association of MHC and rheumatoid arthritis. Regulatory role of HLA class II molecules in animal models of RA: studies on transgenic/knockout mice.

Authors:  V Taneja; C S David
Journal:  Arthritis Res       Date:  2000-04-12

2.  HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Hermann; J Tuokko; R Luukkainen; M Hakala; P Hannonen; M Korpela; U Yli-Kerttula; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

3.  TGF-beta-treated antigen presenting cells suppress collagen- induced arthritis through the promotion of Th2 responses.

Authors:  Sundo Jung; Yoon-Kyung Park; Hyunji Lee; Jung Hoon Shin; Gap Ryol Lee; Se-Ho Park
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

4.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 5.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.

Authors:  E C Andersson; B E Hansen; H Jacobsen; L S Madsen; C B Andersen; J Engberg; J B Rothbard; G S McDevitt; V Malmström; R Holmdahl; A Svejgaard; L Fugger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

Review 7.  HLA transgenic mice as humanized mouse models of disease and immunity.

Authors:  V Taneja; C S David
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

8.  Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis.

Authors:  A La Cava; J L Nelson; W E Ollier; A MacGregor; E C Keystone; J C Thorne; J F Scavulli; C C Berry; D A Carson; S Albani
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

9.  CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis.

Authors:  Soo-Hyun Chung; Keisuke Seki; Byung-Il Choi; Keiko B Kimura; Akihiko Ito; Noriyuki Fujikado; Shinobu Saijo; Yoichiro Iwakura
Journal:  Arthritis Res Ther       Date:  2010-10-12       Impact factor: 5.156

10.  Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis.

Authors:  Veena Taneja; Marshall Behrens; Eati Basal; Josh Sparks; Marie M Griffiths; Harvinder Luthra; Chella S David
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.